Lowenstein Sandler discloses 266,000 shares in Cyabra
Cyabra, Inc. reported a Schedule 13G/A amendment showing Lowenstein Sandler LLP held 266,000 shares of Common Stock as of May 5, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cyabra, Inc. reported a Schedule 13G/A amendment showing Lowenstein Sandler LLP held 266,000 shares of Common Stock as of May 5, 2026. The amendment states this position represents approximately 1.9% of the outstanding common shares, based on 13,814,167 shares outstanding as of March 27, 2026.
Insights
Neutral filing: a passive disclosure of sub-5% beneficial ownership by a law firm.
The amendment records that Lowenstein Sandler LLP beneficially owns 266,000 shares, a 1.9% stake measured against 13,814,167 shares outstanding as of March 27, 2026. The filing is a routine ownership disclosure under Schedule 13G/A and does not indicate an activist intent.
Cash‑flow treatment and any planned transactions are not stated; subsequent filings would be required to show changes in holdings or disposition plans.
Key Figures
Key Terms
Schedule 13G/A regulatory
Beneficially owned regulatory
Sole dispositive power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Lowenstein Sandler report in Cyabra (CYAB)?
What date is the ownership effective for the CYAB Schedule 13G/A amendment?
How is voting and dispositive power reported for this CYAB filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.